Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Nutritional status is associated with disease progression in very mild Alzheimer disease.

Ousset PJ, Nourhashemi F, Reynish E, Vellas B.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):66-71. doi: 10.1097/WAD.0b013e31815a9dbb.

PMID:
18317249
2.

A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort).

Nourhashémi F, Ousset PJ, Gillette-Guyonnet S, Cantet C, Andrieu S, Vellas B; REAL.FR cohort.

Int J Geriatr Psychiatry. 2008 May;23(5):460-5.

PMID:
17894422
3.

Mild cognitive impairment represents early-stage Alzheimer disease.

Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L.

Arch Neurol. 2001 Mar;58(3):397-405.

PMID:
11255443
4.

Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.

Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B; REAL-FR Group.

Alzheimers Dement. 2008 Jan;4(1):22-9. doi: 10.1016/j.jalz.2007.10.018.

PMID:
18631947
5.

Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease.

Lam LC, Tang NL, Ma SL, Lui VW, Chan AS, Leung PY, Chiu HF.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):92-9.

PMID:
16634464
6.

Factors affecting usage patterns of memantine in Alzheimer disease.

Lerner AJ, McClendon MJ, Sami SA, Ogrocki PK, Adams KB, Smyth KA.

Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):137-43. doi: 10.1097/WAD.0b013e31815ccd68.

PMID:
18525285
7.

Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.

Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S.

Int Psychogeriatr. 2009 Feb;21(1):148-56. doi: 10.1017/S1041610208008132. Epub 2008 Dec 1.

PMID:
19040787
9.

Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.

Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML; MK-677 Protocol 30 Study Group.

Neurology. 2008 Nov 18;71(21):1702-8. doi: 10.1212/01.wnl.0000335163.88054.e7.

PMID:
19015485
10.

Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil.

Chaves ML, Camozzato AL, Godinho C, Piazenski I, Kaye J.

J Geriatr Psychiatry Neurol. 2009 Sep;22(3):181-7. doi: 10.1177/0891988709332942. Epub 2009 Mar 23.

PMID:
19307320
11.

[Clinical evaluation of dementia in a cohort of 358 patients with the French version of the Clinical Dementia Rating (CDR) scale].

Ousset PJ, Andrieu S, Reynish E, Puel M, Vellas B.

Rev Med Interne. 2003 Oct;24 Suppl 3:283s-287s. French.

PMID:
14710445
12.

Very mild senile dementia of the Alzheimer type. I. Clinical assessment.

Rubin EH, Morris JC, Grant EA, Vendegna T.

Arch Neurol. 1989 Apr;46(4):379-82.

PMID:
2650663
13.

Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease.

Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, Amouyel P, Pasquier F.

J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):133-9. doi: 10.1136/jnnp.2007.137851. Epub 2008 Oct 31.

PMID:
18977819
14.

Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.

Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH.

Dement Geriatr Cogn Disord. 2008;25(6):483-90. doi: 10.1159/000126499. Epub 2008 Apr 16.

15.

A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease.

Pasqualetti P, Bonomini C, Dal Forno G, Paulon L, Sinforiani E, Marra C, Zanetti O, Rossini PM.

Aging Clin Exp Res. 2009 Apr;21(2):102-10.

PMID:
19448381
16.

Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease.

Gil Gregorio P, Ramirez Diaz SP, Ribera Casado JM; DEMENU group.

J Nutr Health Aging. 2003;7(5):304-8.

PMID:
12917745
17.

Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study.

Cortes F, Gillette-Guyonnet S, Nourhashemi F, Christelle C, Vellas B.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):131-6.

PMID:
16634470
18.

Neuropeptide abnormalities in patients with early Alzheimer disease.

Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V.

Arch Gen Psychiatry. 1999 Nov;56(11):981-7.

PMID:
10565496
19.

Cardiovascular disease risk factors and progression of Alzheimer's disease.

Abellan van Kan G, Rolland Y, Nourhashémi F, Coley N, Andrieu S, Vellas B.

Dement Geriatr Cogn Disord. 2009;27(3):240-6. doi: 10.1159/000203365. Epub 2009 Feb 21.

PMID:
19246908
20.
Items per page

Supplemental Content

Write to the Help Desk